Home » Topics » BioWorld Science

BioWorld Science
RSS

Roche acquisition of Corange approved by U.S. regulators

Feb. 25, 1998

Tedisamil has favorable profile as myocardial antiischemic agent

Feb. 25, 1998

Nucleoside with potent and selective anti-HIV and anti-HBV activity

Feb. 25, 1998

Selective inhibitor of p38 MAP kinase effective in chronic inflammatory diseases

Feb. 25, 1998

FDA advisory committee to vote on expanded label for CEPRATE SC System

Feb. 25, 1998

Biogen sets up Canadian office to promote local development of Avonex

Feb. 25, 1998

Biosearch Italia and Versicor establish infectious disease collaboration

Feb. 25, 1998

Osiris and the University of Cincinnati expand collaboration in tendon regeneration

Feb. 25, 1998

Neurocrine Biosciences: Q4 and FY 1997 highights

Feb. 25, 1998

TRH ineffective as treatment for lung problems in premature infants

Feb. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...